Results 131 to 140 of about 113,904,810 (178)

Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitors. [PDF]

Exp Mol Med
Yoo H, Boo KJ, Nguyen LP, Hwang JI, Lee CS, Yang SH, Jeon SJ, Kim HR, Kim H.   +8 more
europepmc   +1 more source

Effect of Neurokinin-1 Receptor Antagonists on Experimental Postoperative Adhesion: A Systematic Review and Meta-Analysis with Trial Sequential Analysis of Preclinical Studies. [PDF]

Medicina (Kaunas)
Hwang HJ, Choi GJ, Choi YS, Kim BG, Kang H.   +4 more
europepmc   +1 more source

Adverse Event Reporting Patterns Associated with Concomitant Use of 5-HT3 and NK-1 Receptor Antagonists: A Large-Scale Spontaneous-Reporting Analysis. [PDF]

Pharmaceuticals (Basel)
Zhao R, Tang S, Han M, Hu H, Guo J, Lv M, Sun J, Zhou X.   +7 more
europepmc   +1 more source

Neuro-pulmonary mechanistic interplay underlying chronic cough. [PDF]

Breathe (Sheff)
Wingfield Digby J, King J, Smith JA, Alkaraki D, Harkness S, Shaw J, Marsden P.   +6 more
europepmc   +1 more source

Moving beyond promethazine: Advancing precision in antiemetic therapy. [PDF]

SAGE Open Med
Ryan MF, Lagasse C.
europepmc   +1 more source

Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy. [PDF]

J Zhejiang Univ Sci B
Wang Y, Gao J, Cheng Y, Pan H, Tang H, Liu C.   +5 more
europepmc   +1 more source

The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]

Cancers (Basel)
Sánchez ML, Robinson P, Italia Z, Hoang T, Muñoz M, Coveñas R.   +5 more
europepmc   +1 more source

A Dual-Purpose Approach for an Anti-Emetic NK1R Antagonist as a Chemosensitizer and Cardioprotectant in a Preclinical Model of Triple-Negative Breast Cancer. [PDF]

Int J Mol Sci
Muñoz M, Coveñas R, Zuberi Y, Italia Z, Hoang T, Italia Z, Robinson P.   +6 more
europepmc   +1 more source